AMKR vs NVDA

AMKR demonstrates strong financial health with a Piotroski F-Score of 8/9, indicating robust operational efficiency and profitability trends. The company trades at a forward P/E of 18.15, below the sector average of 77.27, suggesting relative undervaluation despite high growth expectations. Earnings growth of 61% YoY and consistent earnings beats (3/4 in last 4 quarters) reinforce its momentum. However, the absence of an Altman Z-Score and bearish insider activity (4 sales totaling $2.83M) introduce cautionary signals. The intrinsic value of $44.25 exceeds the current price of $41.61, supporting a fair value upside.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.